OrthoPediatrics (KIDS)
(Real Time Quote from BATS)
$29.28 USD
+0.07 (0.24%)
Updated Sep 20, 2024 10:54 AM ET
2-Buy of 5 2
D Value F Growth A Momentum D VGM
Cash flow Statements
Fiscal Year End for OrthoPediatrics Corp falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -20.97 | 1.26 | -16.26 | -32.94 | -13.73 |
Depreciation/Amortization & Depletion | 18.37 | 16.71 | 10.68 | 8.01 | 4.67 |
Net Change from Assets/Liabilities | -32.20 | -17.76 | -12.55 | -4.99 | -11.38 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 |
Other Operating Activities | 7.76 | -21.98 | 5.07 | 11.39 | 2.60 |
Net Cash From Operating Activities | -27.05 | -21.77 | -13.06 | -18.53 | -17.77 |
Property & Equipment | -16.88 | -10.03 | -8.10 | -10.50 | -11.82 |
Acquisition/ Disposition of Subsidiaries | -3.64 | -40.09 | -0.65 | -3.39 | -49.84 |
Investments | 64.30 | -63.25 | 9.25 | -55.00 | 0.00 |
Other Investing Activities | -2.11 | 0.00 | -7.91 | -0.80 | -0.27 |
Net Cash from Investing Activities | 41.68 | -113.37 | -7.41 | -69.69 | -61.92 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.02 | 139.35 | 0.14 | 71.86 | 61.14 |
Issuance (Repayment) of Debt | 9.28 | -0.14 | -0.13 | -25.13 | 29.88 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -2.00 | -3.23 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 7.30 | 135.97 | 0.01 | 46.73 | 91.02 |
Effect of Exchange Rate Changes | 0.63 | 0.62 | -0.66 | -0.40 | 0.01 |
Net Change In Cash & Equivalents | 22.57 | 1.46 | -21.13 | -41.90 | 11.34 |
Cash at Beginning of Period | 10.46 | 9.01 | 30.13 | 72.03 | 60.69 |
Cash at End of Period | 33.03 | 10.46 | 9.01 | 30.13 | 72.03 |
Diluted Net EPS | -0.92 | 0.06 | -0.84 | -1.82 | -0.94 |
Fiscal Year End for OrthoPediatrics Corp falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -13.83 | -7.81 | -20.97 | -14.28 | -9.69 |
Depreciation/Amortization & Depletion | 9.81 | 5.03 | 18.37 | 13.18 | 7.93 |
Net Change from Assets/Liabilities | -12.08 | -4.55 | -32.20 | -23.40 | -11.35 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 3.32 | 0.64 | 7.76 | 5.00 | 2.28 |
Net Cash From Operating Activities | -12.78 | -6.69 | -27.05 | -19.50 | -10.83 |
Property & Equipment | -13.14 | -6.46 | -16.88 | -13.04 | -10.56 |
Acquisition/ Disposition of Subsidiaries | -20.69 | -20.69 | -3.64 | -3.64 | -3.10 |
Investments | 49.86 | 23.47 | 64.30 | 40.44 | 27.75 |
Other Investing Activities | 0.00 | 0.00 | -2.11 | 0.00 | 0.00 |
Net Cash from Investing Activities | 16.02 | -3.68 | 41.68 | 23.76 | 14.09 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 0.02 | 0.02 | 0.00 |
Issuance (Repayment) of Debt | -1.34 | -0.57 | 9.28 | -0.11 | -0.07 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -3.50 | 0.00 | -2.00 | -2.00 | -2.00 |
Net Cash from Financing Activities | -4.84 | -0.57 | 7.30 | -2.09 | -2.07 |
Effect of Exchange Rate Changes | -0.53 | 1.48 | 0.63 | -0.40 | -0.34 |
Net Change In Cash & Equivalents | -2.14 | -9.46 | 22.57 | 1.77 | 0.85 |
Cash at Beginning of Period | 33.03 | 33.03 | 10.46 | 10.46 | 10.46 |
Cash at End of Period | 30.89 | 23.56 | 33.03 | 12.23 | 11.31 |
Diluted Net EPS | -0.26 | -0.34 | -0.29 | -0.20 | -0.13 |